Skip to main content
Premium Trial:

Request an Annual Quote

RADx Awards Minute Molecular Diagnostics $21.3M for Rapid PCR COVID-19 Test

NEW YORK – Minute Molecular Diagnostics has been awarded a $21.3 million contract from the US National Institutes of Health Rapid Acceleration of Diagnostics, or RADx, program to support the development of its Diagnostic Analyzer for Specific Hybridization, or DASH, PCR system and SARS-CoV-2 assay.

The DASH system is a rapid, cartridge-based, point-of-care molecular diagnostics instrument codeveloped by Evanston, Illinois-based Minute Molecular and Northwestern University's Center for Innovation in Global Health Technologies. The DASH SARS-CoV-2 assay tests patient samples directly from nasal swabs, providing PCR results in approximately 15 minutes. 

"We are pleased to receive support from NIH through the RADx initiative to scale our innovative technology during this critical time of need," said David Kelso, president and CEO of Minute Molecular Diagnostics, in a statement. "DASH performs point-of-care PCR testing for COVID-19 in approximately 15 minutes, providing an important, new tool for safely reopening K-12 schools, universities, and workplaces," he said.

RADx has awarded more than $1.2 billion to developers to support SARS-CoV-2 diagnostics scale up.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more